Tụlee 'Irifrin': reviews na ntuziaka maka ojiji

Nkwadebe "Irifrin" bụ a symptomatic gị n'ụlọnga nke na-eji ophthalmology maka nchoputa ma belata intraocular nsogbu.

Pharmacology na ụdị "Irifrin" ọgwụ

Nyocha ọkachamara na ntuziaka maka ojiji na-agụnye ọmụma na isi nọ n'ọrụ umi omume dị ka phenylephrine hydrochloride, nke gbatịrị nwa akwụkwọ constricts nile nke conjunctiva ma na-enye ihe outflow nke intraocular ọmụmụ.

Mgbe a otu instillation mydriasis emee n'ime awa na dịruru, dabere na elekere abụọ ngwọta (2.5%) ma ọ bụ ruo 7 awa (10%).

The ọgwụ nwere dịghị utịp ke ụjọ usoro na n'obi.

The ọgwụ na-emepụta n'ụdị uzo colorless tụlee, ịbụ na plastic ma ọ bụ iko karama.

The iji "Irifrin" ọgwụ

Nyocha ophthalmologists na-ekwu banyere ịdị irè tụlee nchọpụta mgbe enyo enyo mmechi glaucoma, nyochaa ala nke posterior nke nke pelvis n'oge ophthalmoscopy, na ogwu ogbugba nke nwa anya.

Ke adianade do, ọgwụ ọjọọ, "Irifrin" (tụlee) a na-eji na-emeso glaucoma tsikliticheskih ọdụdọ, red anya syndrome, myopia, n'ihi visual nchegbu, ọgwụ na-ebelata anya iyatesịt na flushing membranes.

Nke ogwugwo na ngwá ọrụ na-eji na vitreoretinal arụmọrụ ka e si laser nnyonye anya na fundus, aka ụmụ akwụkwọ tupu ịwa ahụ.

Ọzọkwa agwọ ọrịa na-enwe a prophylactic mmetụta na myopia na iridocyclitis.

Contraindications iji "Irifrin" nkwadebe

Nyocha nke dọkịta na-enye ndụmọdụ na-eji tụlee ke ọrịa na nke thyroid gland, na zakryto- na warara-n'akuku glaucoma, na ọrịa nke obi na vaskụla usoro (aortic aneurysm, tachycardia, gbasara obi arrhythmias, mụbara ọbara mgbali).

Anakwere ojiji nke ọgwụ na-arịa ọrịa shuga, ndị ọzọ na mydriasis, hepatic porphyria, nakwa dị ka ụba uche na mmiri "Irifrin" ọgwụ ọjọọ.

Anya tụlee testimonials si ọrịa na dọkịta na-nti, n'agbanyeghị eziokwu na ha na-adịghị kenyere maka imekotaotuugbo ojiji nke tricyclic antidepressants, antihypertensive ọgwụ ọjọọ, monoamine oxidase inhibitors. Mgbe eji na tụlee ka ụmụ na lactation.

mmetụta

The ọgwụ nwere ike ime ka dị iche iche ọrịa na akụkụ nke ọhụụ, conjunctivitis, ma ọ bụ periorbital edema. Na ngwa nke na o kwere omume mgbu na a na-ere sensashion na anya, ahụ erughị ala, ahụ inyoghi inyoghi, lacrimation. Ọzọkwa, mụbara intraocular nsogbu. On ụbọchị nke abụọ nke na-anata ego na ndị agadi nwere ike ime reactive miosis, nke mechara na-aga.

Mgbe ụfọdụ, nsogbu na-amụba mgbe ojiji nke agwọ ọrịa na-aghọ ugboro ugboro palpitations, kọntaktị dermatitis emee, tachycardia na arrhythmia hụrụ.

Dosing "Irifrin" nkwadebe

Ọrịa comments na ntụziaka e nyere ndị na-esonụ ndụmọdụ na nke ọgwụ. The ọgwụ na-eji singly maka nchoputa, ngwọta (2.5%) e kụnyere n'ime conjunctival nwa. Na obere mmetụta usoro ugboro ugboro mgbe otu awa.

N'ihi na ọgwụgwọ nke glaucoma na iridocyclitis bụla 8 awa na-atasị otu dobe mgbe ọ bụla ịta nke ihe ngwọta, na N'ezie nke ọgwụ bụ 10 ụbọchị.

Mgbe myopia mere site elu ibu na anya, ma ọ bụ spasm nke ulo otu dobe tupu alakpu ụra ọgwụ na-atụ aro (2.5%). Ọ bụrụ na ọrịa ahụ na-aga n'ihu, ọgwụ na-eji 3 ugboro n'ụbọchị.

N'ihi mgbochi nke myopia ụmụ akwụkwọ na ụba visual ibu inye otu dobe tupu alakpu ụra maka a ọnwa na nkịtị - na-ada ada site na ụbọchị.